Samarth Kulkarni, Ph.D.
Chairman
CRISPR Therapeutics AG (CRSP)Equibles does not estimate personal net worth.
Get an email with a short summary when CRISPR Therapeutics AG publishes a filing, an earnings call transcript or a press release.
Get CRSP alertsAbout Samarth Kulkarni, Ph.D.
Samarth Kulkarni, Ph.D. is recorded as Chairman at CRISPR Therapeutics AG (CRSP) since May 30, 2024. CRISPR Therapeutics AG reported in an 8-K filed September 7, 2023 that Samarth Kulkarni, Ph.D. was appointed Chairman of the Board, effective September 15, 2023. CRISPR Therapeutics AG is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CRISPR Therapeutics AG includes Samarth Kulkarni (CEO), Andrew J. Silver (CFO and Chief Accounting Officer), Raju Prasad (CFO) and 7 others.
“the Board appointed Samarth Kulkarni, Ph.D., the Company's Chief Executive Officer and a current member of the Board, as Chairman of the Board, effective as of the Resignation Date, and Dr. Kulkarni shall serve in such capacity for a term ending at the next annual general meeting of the Company's shareholders.”
Affiliation history
-
Current
2024-05-30–present
Company network
Leadership on record at CRISPR Therapeutics AG
- Samarth Kulkarni CEO
- Andrew J. Silver CFO, Chief Accounting Officer
- Raju Prasad CFO
- Raju Prasad, Ph.D. CFO, Chief Accounting Officer
- Julianne Bruno COO
- James R. Kasinger General Counsel
- Ali Behbahani Board Member
- Briggs W. Morrison Board Member
- Christian Rommel Board Member
- Christian Rommel, Ph.D. Board Member